Abstract: A facemask system with automated voice display is disclosed. The facemask includes a covering configured to be positioned about the face of a user. At least one microphone is positioned adjacent the covering and the facemask includes a display for displaying language spoken captured by at least one microphone. A processor is in operable communication with the microphone and the display. The facemask includes a memory that contains instructions that can be executed by the processor to perform operations. The operations include receiving signals from at least one microphone, identifying language contained within the signals, and displaying the language on the display.

Abstract: A facemask system with automated voice display is disclosed. The facemask includes a covering configured to be positioned about the face of a user. At least one microphone is positioned adjacent the covering and the facemask includes a display for displaying language spoken captured by at least one microphone. A processor is in operable communication with the microphone and the display. The facemask includes a memory that contains instructions that can be executed by the processor to perform operations. The operations include receiving signals from at least one microphone, identifying language contained within the signals, and displaying the language on the display.

Abstract: Embodiments of the disclosed computer systems provide rapid design of multiple component products, especially medical products, as well as determination of manufacturing costs, pricing, physical attributes, component bonding techniques, sterilization techniques, and government regulatory approval. Certain embodiments also generate work orders, product labels, and audits for multiple component devices.

Abstract: A HIV-1 protease inhibitor which includes a n-terminal cycle (A) or a C-terminal cycle (B) or both cycles (A) and (B) wherein Y is selected from side chains of Asn or Ilc or Val or Glu and alkyl of 1-6 carbon atoms inclusive of linear branched chains as well as cycloalkyl; and X is selected from (CH2)n where n=3-6, --CH(OH)--CH(OH)--CH2; CH(CO2H)--CH2--CH2; CH2CONHCHR where R=D or L amino acids and alkyl of 1-6 carbon atoms inclusive of linear or branched chains.